LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10127-1 | Dovitinib | TKI_258; TKI258 | LSM-1127 |  | 49830557 |
| 10069-1 | Enzastaurin | LY317615 | LSM-1069 |  | 176167 |
| 10097-1 | Erlotinib | OSI-774 | LSM-1097 |  | 176870 |
| 10141-1 | Fedratinib | SAR 302503; SAR-302503; SAR302503; TG 101348; Tg-101348; TG101348 | LSM-1142 |  | 16722836 |
| 10157-1 | Foretinib | XL880; GSK1363089 | LSM-1158 |  | 42642645 |
| 10234-1 | GDC-0980 | RG7422 | LSM-4257 |  | 66694608 |
| 10098-1 | Gefitinib | ZD1839; Iressa | LSM-1098 |  | 123631 |
| 10108-1 | Geldanamycin | LSM-42789 |  | 644250 | |
| 10172-1 | GSK1059615 | LSM-1173 |  | 71317162 | |
| 10134-1 | GSK1904529A | LSM-1134 |  | 25124816 | |
| 10128-1 | GSK 690693 | LSM-1128 |  | 16048642 | |
| 10014-1 | GW843682X | GW843682 | LSM-1014 |  | 9826308 |
| 10015-1 | HG-5-113-01 | LSM-5982 |  | 25226483 | |
| 10016-1 | HG-5-88-01 | LSM-5245 |  | 25226117 | |
| 10017-1 | HG-6-64-01 | KIN001-206 | LSM-43248 |  | |
| 10023-1 | Imatinib | Gleevec; Glivec; CGP-57148B; STI-571 | LSM-1023 |  | 5291 |
| 10100-1 | JNK-9L | KIN001-204 | LSM-36386 |  | 25222038 |
| 10019-1 | JW-7-24-1 | LSM-5674 |  | 69923936 | |
| 10031-1 | KIN001-043 | LSM-42780 |  | 24906282 | |
| 10051-1 | Lapatinib | GW-572016; Tykerb | LSM-1051 |  | 208908 |
| 10115-1 | LDN-193189 | DM 3189 | LSM-1115 |  | 25195294 |
| 10182-1 | Linifanib | ABT-869; AL-39324 | LSM-1183 |  | 11485656 |
| 10135-1 | Linsitinib | OSI 906 | LSM-1135 |  | 11640390 |
| 10161-1 | Luminespib | NVP-AUY922 | LSM-1162 |  | 53401173 |
| 10479-1 | Mitoxantrone | CL 232325; CL-232325; DHAQ; Novantron; Novantrone | LSM-2481 |  | 4212 |